Fidelity International
RPRX icon

Fidelity International’s Royalty Pharma RPRX Stock Holding History

Fidelity International’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
23,526
-98,523
-81% -$5.13M ﹤0.01% 819
2026
Q1 		$5.85M Sell
122,049
-191,461
-61% -$8.39M ﹤0.01% 666
2025
Q4 		$12.1M Buy
313,510
+112,150
+56% +$4.28M 0.01% 558
2025
Q3 		$7.1M Buy
201,360
+154,800
+332% +$5.6M 0.01% 610
2025
Q2 		$1.68M Buy
46,560
+2,720
+6% +$90.1K ﹤0.01% 709
2025
Q1 		$1.36M Sell
43,840
-4,856
-10% -$154K ﹤0.01% 705
2024
Q4 		$1.24M Sell
48,696
-3,242
-6% -$86K ﹤0.01% 714
2024
Q3 		$1.47M Buy
51,938
+5,319
+11% +$147K ﹤0.01% 706
2024
Q2 		$1.23M Buy
46,619
+23,638
+103% +$655K ﹤0.01% 717
2024
Q1 		$698K Buy
22,981
+1,621
+8% +$47.8K ﹤0.01% 743
2023
Q4 		$600K Buy
21,360
+1,599
+8% +$43.9K ﹤0.01% 729
2023
Q3 		$536K Buy
19,761
+1,816
+10% +$53.9K ﹤0.01% 718
2023
Q2 		$552K Sell
17,945
-1,361
-7% -$46.1K ﹤0.01% 713
2023
Q1 		$696K Buy
19,306
+11,406
+144% +$423K ﹤0.01% 731
2022
Q4 		$312K Buy
+7,900
New +$330K ﹤0.01% 748

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity International's RPRX Position: Q2 2026 in Review

Fidelity International reduced its Royalty Pharma (RPRX) stake by 81% in Q2 2026, selling an estimated $5.13M and leaving 23,526 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Fidelity International first reported a position in RPRX in Q4 2022 and has held it in 15 quarters since. The position peaked at $12.1M in Q4 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Fidelity International held 23,526 shares of Royalty Pharma worth $1.32M as of Q2 2026.
  • Fidelity International sold 98,523 Royalty Pharma shares in Q2 2026, an estimated $5.13M.
  • Royalty Pharma made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #819 holding.
  • Fidelity International first reported a position in Royalty Pharma in Q4 2022 and has held it in 15 quarters since.
  • Fidelity International's Royalty Pharma position peaked at $12.1M in Q4 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.